Royalty Report: Diagnostic, Medical, Disease – Collection: 7259

$100.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3

Primary Industries

  • Diagnostic
  • Medical
  • Disease
  • Cancer
  • Drugs
  • Biotechnology

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 7259

License Grant
Licensor hereby grants to Licensee, and Licensee hereby accepts, (a) an exclusive, worldwide license under the Patent Rights, with the right to grant Sublicenses, to make, have made, sell, have sold, offer to sell, import and export tangible Licensed Products for the Markets in the Field in the Territory.
License Property
Licensor, as a corporation developing, manufacturing and selling products for pharmaceutical research and development, biopharmaceutical manufacturing, medical devices, diagnostics and sensor systems holds the intellectual property rights to the CARAâ„¢ technologies. Licensor is the owner of the Patent Rights.  Licensee wished to obtain a license under the Patent Rights that is exclusive and with the right to sub-license.

“Licensed Product” means (i) any composition of matter or tangible article (for example, a reagent, kit, or instrument) that is covered by any pending or issued claim within the Patent Rights and/or the use, production or sale of which would constitute, but for the grant of a license under the Patent Rights within the Field, an infringement of any Valid Claim in the country in which such product is used, produced or sold, (ii) any composition of matter or tangible article (for example, a reagent, kit, or instrument) that is produced according to or through the use of a Licensed Method, (iii) any composition of matter or tangible article (for example, a reagent, kit, or instrument) sold for use predominantly in the performance of a Licensed Method, and (iv) any composition of matter or tangible article (for example, a reagent, kit, or instrument) that includes or results from Licensor’s Technology.

“Licensor’s Technology“ means the research and development knowledge, experience, technical data, methods, applications and the like concerning artificial receptor technology or methods, synthetic competitor agent technology or methods, sensing system technology or methods which Licensor had in its possession or acquired on or before the date of this Agreement and which Licensor creates during the effective term of this Agreement, including methods of making any Licensed Product or part thereof and any compositions, articles, methods or artificial receptor technology or methods, synthetic competitor technology or methods, sensing system technology or methods disclosed but not claimed in any patent or patent application owned and controlled by Licensor. The term Licensor’s Technology does not include any information which has been acquired or is acquired by Licensor in confidence from a third party.

“Markets” means Diagnostics – an Implantable Glucose Sensing Device for use in the human body markets and applicational areas in the Field.

Field of Use
“Field” means the field of methods and products for glucose sensing for use in the human body employing Licensor proprietary artificial receptor technology or methods, synthetic competitor agent technology or methods, or sensing system technology or methods.

IPSCIO Record ID: 25900

License Grant
Licensor grants to Licensee an exclusive, worldwide license under the Patent Rights, with the right to grant Sublicenses, to make, have made, sell, have sold, offer to sell, import and export tangible Licensed Products, and an exclusive license to sell Service, and to use the Patent Rights and Licensor's Technology for internal research, internal development and internal quality control purposes, with no right to grant Sublicenses except that Licensee shall have the right to grant any Sublicensees a Sublicense to use the Patent Rights and Receptor's Technology solely for internal research, internal development and internal quality control purposes.
License Property
Licensor, a corporation developing, manufacturing and selling products for pharmaceutical research and development, biopharmaceutical manufacturing, medical devices, diagnostics and sensor systems holds the intellectual property rights to the CARAâ„¢ technologies.
Field of Use
Field means the field of methods and products for glucose sensing for use in the human body or in animals, employing Licensor's proprietary artificial receptor technology or methods, synthetic competitor agent technology or methods, or sensing system technology or methods.

Markets  means Diagnostics – an Implantable Glucose Sensing Device for use in the human body markets, the animal markets, and applicational areas in the Field.

IPSCIO Record ID: 3977

License Grant
The Licensee entered into a License Agreement with the Licensor to obtain an exclusive License to use certain intellectual property of the Licensor for internal research, internal development and quality control purposes and to make, sell, offer to sell, import and export tangible products covered by patents and patent applications owned by the Licensor, including Patent No. 7,504,364 titled “Methods of Making Arrays and Artificial Receptors” and Patent No. 7,469,076 “Sensors Employing Combinatorial Artificial Receptors,” in their application to the development of the virus triage detection system for the detection and identification of the influenza virus, including, but not limited to the H1N1 virus.
License Property
Licensor is engaged in the research and development of applying Receptors’ patented AFFINITY by DESIGNTM CARATM platform to the detection and classification of pandemic threat viruses, such as the H1N1 virus, as well as the research and development of an in vivo glucose-sensing RFID microchip.
Field of Use
“FIELD” means the field of methods and products for the detection and sub-type identification of the influenza virus employing LICENSOR’s proprietary artificial receptor technology or methods, synthetic competitor agent technology or methods, or sensing system technology or methods.

“MARKETS” means Diagnostics – Point of Care and Diagnostics – Clinical Laboratory markets and applicational areas in the FIELD.

Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.